Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
In a similar way, when gut tissue becomes inflamed, KPV is preferentially taken up into that inflamed tissue to help shut down the inflammatory response
Anti-Inflammatory Effects: Exploration of its potential to reduce chronic inflammation in conditions such as arthritis or gastrointestinal disorders
Higher doses or specialized formulations are often required for oral peptides to compensate for degradation and limited systemic uptake
Product Attributes CAS # : 1034043-18-3 Molecular Formula : C10H11N2+ (free base), C10H11IN2 (iodide salt), C10H11ClN2 (chloride salt) Sequence (AA) : N/A (small molecule) Molecular Weight : 215.26 g/mol PubChem CID : 950107 (free base), 66522933 (iodide salt) Half-Life : 3.8-6.9 hours Synonyms : 5-Amino-1-methylquinolinium-1-ium, NNMT Inhibitor 5A1MQ, NNMTi, Amino-1MQ, 1-MQ, Type : Synthetic small molecule analog Research Focus : Weight Loss, Mitochondrial Function, Longevity, Metabolic Health Scientific References Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice Animal Roles of nicotinamide N-methyltransferase in obesity and type 2 diabetes mellitus Review What is 5-Amino-1MQ
Prescribers initiating BPC-157 in patients with Child-Pugh A or B hepatic impairment should document: (1) the clinical rationale for peptide therapy, (2) the absence of an FDA-approved alternative for the target condition, (3) baseline hepatic function with planned monitoring intervals, and (4) the patient's informed consent acknowledging the investigational nature of the therapy and the specific evidence limitations in their population
